Skip to main content

ScienceDex / Researcher record

Adam P Bress

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #1,985
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Mentor
  • Diverse Portfolio

NIH Funding · FY2026

$6.2M
Full award amounts, FY2026
4
Records listing this PI
#1,985
By linked amount among FY2026 PIs
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$1,045,3713#14,310
2025$7,087,3355#816
2026$6,150,7474#1,985

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20243 records
  2. FY20255 records
  3. FY2026 · selected4 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Adam P Bress. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2027 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11206163Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award categories

  • Public Health
  • Pediatrics

FY2026 award records by amount

NIH award records listing Adam P Bress as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG096179-02R01Contact PI
    Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the SPRINT trial
    University of Utah · Public Health (NIH department code)
    $5M
    award amount
  • 1R01AG097580-01R01Contact PI
    Real-world evidence to clarify risk-benefit of antihypertensive intensification vs. de-escalation and blood pressure thresholds to minimize harms and maximize brain and heart health in older adults
    University of Utah · Public Health (NIH department code)
    $660.5K
    award amount
  • 5T32HD114565-02T32Co-investigator
    Utah Pediatric Clinical Pharmacology Training Program
    University of Utah · Pediatrics (NIH department code)
    $288.3K
    award amount
  • 5K24AG080168-04K24Contact PI
    Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring.
    University of Utah · Public Health (NIH department code)
    $198.2K
    award amount

Award organization

Organizations that administered FY2026 awards listing Adam P Bress as a PI.

FY2026 award administered by University of Utah (UT).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Utah
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    $5M Cumulative Funding
  6. 2025
    Entered Top 50% Nationally
    Ranked #816
  7. 2025
    Entered Top 25% Nationally
    Ranked #816
  8. 2025
    Entered Top 10% Nationally
    Ranked #816
  9. 2025
    Entered Top 5% Nationally
    Ranked #816
  10. 2025
    R01 Grant Holder
  11. 2026
    $10M Cumulative Funding